Hoth Therapeutics Signs Deal with Aronnax for HT-KIT Cancer Therapeutic
Hoth Therapeutics has signed a Master Services Agreement with Aronnax, Inc. for its HT-KIT cancer therapeutic.
HT-KIT Research | 16/08/2024 | By Aishwarya | 153
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy